MENU
UNCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Unicycive Therapeutics (UNCY) Ownership - Who owns Unicycive Therapeutics?
Profile
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.61M
P/E Ratio
N/A
Total Cash
32.35M
Projected Growth
N/A
Total Debt
807K
Revenue
N/A
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
UNCY
Capitalization
72.6M
P/E Ratio
N/A
Risk (Beta)
2.51
Dividend Yield
N/A
Total Cash
32.3M
Total Cash/Share
0.31
Total Debt
807K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
27.8M
P/B Ratio
2.61
Cash Flow
N/A
Earnings
-0.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
98K
Current Ratio
3.61
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-22.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-83.07
Shares Held By Institutions
11.6M
Shares Outstanding - Current
104M
Total Liabilities
10.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-19.385
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com